TY - JOUR
AU - Chesterman, Thomas
AU - Thynne, Tilenka RJ
TI - Harms and benefits of sodium‑glucose co‑transporter 2 inhibitors
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2020
VL - 43
SP - 168
EP - 171
DO - 10.18773/austprescr.2020.049
LA - eng
UR - https://australianprescriber.tg.org.au/articles/harms-and-benefits-of-sodium-glucose-co-transporter-2-inhibitors.html
KW - canagliflozin
KW - dapagliflozin
KW - empagliflozin
KW - ertugliflozin
KW - diabetes
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -